Podometrics as a Potential Clinical Tool for Glomerular Disease Management

Seminars in Nephrology

Volumn 35, Issue 3, 2015, Pages 245-255

  Kikuchi, Masao ^a   Wickman, Larysa ^b   Hodgin, Jeffrey B ^a   Wiggins, Roger C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Kidney failure; Podocyte; Podometrics; Prevention; Progression

Indexed keywords

MESSENGER RNA; PODOCIN;

CELL COUNT; CELL CYCLE; CELL DENSITY; CELL SIZE; CLINICAL ASSESSMENT TOOL; CLINICAL DECISION MAKING; END STAGE RENAL DISEASE; GLOMERULAR STRUCTURE; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; PODOCYTE; PODOMETRICS; PRIORITY JOURNAL; PROTEINURIA; REVIEW; URINALYSIS; DISEASE COURSE; DISEASE MANAGEMENT; GLOMERULONEPHRITIS; GLOMERULUS; PATHOLOGY;

DISEASE MANAGEMENT; DISEASE PROGRESSION; GLOMERULONEPHRITIS; HUMANS; KIDNEY GLOMERULUS; PODOCYTES;

EID: 84937969165     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2015.04.004     Document Type: Review

References (40)

1. NIDDK, US Department of Health and Human Services web site. USRDS 2012 annual data report. Vol 2. Costs of ESRD, Chapter 11. Available at: http://usrds.org (Last accessed May 21, 2015).
2. United States Organ Procurement and Transplant Network and Scientific Registry of Transplant Recipients (OPTN/SRTR) annual data report 2012. Kidney. Chapter 8. Medicare data. Available at: http://srtr.transplant.hrsa.gove/annual_reports/2012/pdf (Last accessed May 21, 2015).
3. Wiggins R. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007, 71:1205-1214.
4. Kriz W., Gretz N., Lemley K.V. Progression of glomerular diseases: is the podocyte the culprit?. Kidney Int 1998, 54:687-697.
5. Kriz W. Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 2002, 57:189-195.
6. Kriz W., LeHir M. Pathways to nephron loss starting from glomerular diseases: insights from animal models. Kidney Int 2005, 67:404-419.
7. Kim Y.H., Goyal M., Kurnit D., Wharram B., Wiggins J., Holzman L., et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 2001, 60:957-968.
8. Wharram B.L., Goyal M., Gillespie P.J., Wiggins J.E., Kershaw D.B., Holzman L.B., et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005, 16:2941-2952.
9. Fukuda A., Wickman L.T., Venkatareddy M.P., Sato Y., Chowdhury M.A., Wang S.Q., et al. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int 2012, 81:40-55.
10. Fukuda A., Chowdhury M., Venkatareddy M., Wang S.Q., Nishizono R., Wickman L., et al. Growth-dependent podocyte failure causes glomerulosclerosis. J Am Soc Nephrol 2012, 23:1351-1363.
11. Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, et al the SRNS Study Group. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2015. Epub ahead of print.
12. Pagtalunan M.E., Miller P.L., Jumping-Eagle S., Nelson R.G., Myers B.D., Rennke H.G., et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997, 99:342-348.
13. Meyer T.W., Bennett P.H., Nelson R.G. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia 1999, 42:1341-1344.
14. Steffes M.W., Schmidt D., McCrery R., Basgen J.M. International Diabetic Nephropathy Study Group: glomerular cell number in normal subjects and type I diabetes patients. Kidney Int 2001, 59:2104-2113.
15. White K.E., Bilous R.W., Marshall S.M., El Nahas M., Remuzzi G., Piras G., et al. European Study for the Prevention of Renal Disease in Type I diabetes (ESPRIT): podocyte number in normotensive type I diabetic patients with albuminuria. Diabetes 2002, 51:3083-3089.
16. Lemley K.V., Lafayette R.A., Safai M., Derby G., Blouch K., Squarer A., et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002, 61:1475-1485.
17. Della Vestra M., Masiero A., Roiter A.M., Saller A., Crepaldi G., Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 2003, 52:1031-1035.
18. Wang G., Lai F.M., Kwan B.C., Lai K.B., Chow K.M., Li P.K., et al. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 2009, 22:300-306.
19. Yang Y., Hodgin J., Afshinnia F., Wang S., Wickman L., Chowdhury M., et al. The two kidney to one kidney transition and transplant glomerulopathy: a podocyte perspective. J Am Soc Nephrol 2015, 26. Epub ahead of print.
20. Wanner N., Hartleben B., Herbach N., Goedel M., Stickel N., Zeiser R., et al. Unraveling the role of podocyte turnover in glomerular aging and injury. J Am Soc Nephrol 2014, 25:707-716.
21. Venkatareddy M., Wang S.Q., Yang Y., Patel S., Wickman L., Nishizono R., et al. Estimating podocyte number and density in histologic sections. J Am Soc Nephrol 2014, 25:1118-1129.
22. Sato Y., Wharram B.L., Lee S.K., Wickman L., Goyal M., Venkatareddy M., et al. Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol 2009, 20:1041-1052.
23. Wickman L., Afshinnia F., Yang Y., Wang S.Q., Wang F., Chowdhury M., et al. Urine podocyte mRNAs, proteinuria and progression in human glomerular diseases. J Am Soc Nephrol 2013, 24:2081-2095.
24. Puelles V., Hoy W., Hughson M., Diouf B., Douglas-Denton R., Bertram J. Glomerular number and size variability and risk for kidney disease. Curr Opin Nephrol Hypertens 2011, 20:7-15.
25. Kanzaki G., Tsuboi N., Utsonomiya Y., Ikegami M., Shimutsu A., Hosoya T. Distribution of glomerular density in different cortical zones of the human kidney. Pathol Int 2013, 63:169-175.
26. Hodgin J, Bitzer M, Wickman L, Afshinnia F, Wang S, Yang Y, et al. Kidney aging and focal global glomerulosclerosis. A podometric perspective. J Am Soc Nephrol. Accepted for publication.
27. Lasagni L., Lazzeri E., Shankland S., Anders H.-J., Romagnani P. Podocyte mitosis-a catastrophe. Curr Mol Med 2013, 13:13-23.
28. Cho C.R., Lumsden C.J., Whiteside C.I. Epithelial cell detachment in the nephritic glomerulus: a receptor co-operativity model. J Theor Biol 1993, 160:407-426.
29. Ichikawa I., Ma J., Motojima M., et al. Podocyte damage damages podocytes: autonomous vicious cycle that drives local spread of glomerular sclerosis. Curr Opin Nephrol Hypertens 2005, 14:205-210.
30. Cui S., Guo G., Li C., Willecke K., Quaggin S.E. Innocent bystander theory for progression to glomerulosclerosis in a transgenic mouse model [abstract]. J Am Soc Nephrol 2004, 15:241A.
31. Craici I.M., Wagner S.J., Weissgerber T.L., Grande J.P., Garovic V.D. Advances in the pathophysiology of pre-eclampsia and related podocyte injury. Kidney Int 2014, 86:275-285.
32. Craici I.M., Wagner S.J., Bailey K.R., Fitz-Gibbon P.D., Wood-Wentz C.M., Turner S.T., et al. Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension 2013, 61:1289-1296.
33. Hara M., Yanagihara T., Kihara I. Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 2001, 89:342-347.
34. Hara M., Yanagihara T., Kihara I., Higashi K., Fujimoto K., Kajita T. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. J Am Soc Nephrol 2005, 16:408-416.
35. Hara M., Yanagihara T., Hirayama Y., Ogasawara S., Kurosawa H., Sekine S., et al. Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. Hum Pathol 2010, 41:1265-1275.
36. Fukuda A., Wickman L., Venkatareddy M., Wang S.Q., Chowdhury M., Wiggins J., et al. Urine podocin:nephrin mRNA ratio as a podocyte stress biomarker. Nephrol Dial Transplant 2012, 27:4079-4087.
37. Wiggins J., Goyal M., Sanden S., Wharram B., Shedden K., Misek D., et al. Podocyte hypertrophy, "adaptation" and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 2005, 16:2953-2966.
38. Song T., Fu L., Huang Z., He S., Zhau R., Lin T., et al. Change in renal parenchymal volume in living transplant donors. Int Urol Nephrol 2013, 46:743-747.
39. Pamukcu B., Lip G.Y., Shantsila E. The nuclear factor-kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. Thromb Res 2011, 128:117-123.
40. Wiggins J.E., Patel S., Shedden K., Goyal M., Wharram B., Martini S., et al. NFkB in the pro-inflammatory, pro-coagulant, pro-fibrotic aging glomerulus. J Am Soc Nephrol 2010, 21:587-597.